Literature DB >> 31399244

Morbidity of Persistent Pulmonary Hypertension of the Newborn in the First Year of Life.

Martina A Steurer1, Rebecca J Baer2, Scott Oltman3, Kelli K Ryckman4, Sky K Feuer5, Elizabeth Rogers6, Roberta L Keller7, Laura L Jelliffe-Pawlowski3.   

Abstract

OBJECTIVE: To assess postdischarge mortality and morbidity in infants diagnosed with different etiologies and severities of persistent pulmonary hypertension of the newborn (PPHN), and to identify risk factors for these adverse clinical outcomes. STUDY
DESIGN: This was a population-based study using an administrative dataset linking birth and death certificates, hospital discharge and readmissions records from 2005 to 2012 in California. Cases were infants ≥34 weeks' gestational age with International Classification of Diseases,9th edition, codes consistent with PPHN. The primary outcome was defined as postdischarge mortality or hospital readmission during the first year of life. Crude and adjusted risk ratio (aRR) with 95% CIs were calculated to quantify the risk for the primary outcome and to identify risk factors.
RESULTS: Infants with PPHN (n = 7847) had an aRR of 3.5 (95% CI, 3.3-3.7) for the primary outcome compared with infants without PPHN (n = 3 974 536), and infants with only mild PPHN (n = 2477) had an aRR of 2.2 (95% CI, 2.0-2.5). Infants with congenital diaphragmatic hernia as the etiology for PPHN had an aRR of 8.2 (95% CI, 6.7-10.2) and infants with meconium aspiration syndrome had an aRR of 4.2 (95% CI, 3.7-4.6) compared with infants without PPHN. Hispanic ethnicity, small for gestational age, severe PPHN, and etiology of PPHN were risk factors for the primary outcome.
CONCLUSIONS: The postdischarge morbidity burden of infants with PPHN is large. These findings extend to infants with mild PPHN and etiologies with pulmonary vascular changes that are thought to be short term and recoverable. These data could inform counseling of parents.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31399244     DOI: 10.1016/j.jpeds.2019.06.053

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Optimal Oxygen Targets in Term Lambs with Meconium Aspiration Syndrome and Pulmonary Hypertension.

Authors:  Munmun Rawat; Praveen Chandrasekharan; Sylvia F Gugino; Carmon Koenigsknecht; Lori Nielsen; Stephen Wedgwood; Bobby Mathew; Jayasree Nair; Robin Steinhorn; Satyan Lakshminrusimha
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

2.  Postnatal causes and severity of persistent pulmonary Hypertension of Newborn.

Authors:  Muhammad Sohail Arshad; Mudasser Adnan; Hafiz Muhammad Anwar-Ul-Haq; Arif Zulqarnain
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

3.  [Early risk factors for death in neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide].

Authors:  Ai-Min Qian; Wen Zhu; Yang Yang; Ke-Yu Lu; Jia-Li Wang; Xu Chen; Chu-Chu Guo; Ya-Dong Lu; Hui Rong; Rui Chneg
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

Review 4.  Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Meta-Analysis of Pharmacotherapy.

Authors:  Meera Viswanathan; Jennifer Cook Middleton; Alison M Stuebe; Nancy D Berkman; Alison N Goulding; Skyler McLaurin-Jiang; Andrea B Dotson; Manny Coker-Schwimmer; Claire Baker; Christiane E Voisin; Carla Bann; Bradley N Gaynes
Journal:  Psychiatr Res Clin Pract       Date:  2021-05-04

5.  Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Authors:  Na Zhu; Emilia M Swietlik; Carrie L Welch; Michael W Pauciulo; Nicholas W Morrell; Yufeng Shen; Stefan Gräf; William C Nichols; Wendy K Chung; Jacob J Hagen; Xueya Zhou; Yicheng Guo; Johannes Karten; Divya Pandya; Tobias Tilly; Katie A Lutz; Jennifer M Martin; Carmen M Treacy; Erika B Rosenzweig; Usha Krishnan; Anna W Coleman; Claudia Gonzaga-Jauregui; Allan Lawrie; Richard C Trembath; Martin R Wilkins
Journal:  Genome Med       Date:  2021-05-10       Impact factor: 15.266

6.  Risk Factors and Outcomes of Acute Kidney Injury in Neonates with Persistent Pulmonary Hypertension of the Newborn.

Authors:  Nuran Ustun; Fahri Ovali
Journal:  Medeni Med J       Date:  2021-09-30

7.  Risk Factors of Persistent Pulmonary Hypertension in Neonate in A Tertiary Care Referral Center.

Authors:  Essam I Jastania; Mohammed S Alqarni; Abdulkarim W Abukhodair; Ziad M Bukhari; Rima A Bukhari; Sawsan Khatrawi; Norah Alsomali; Rahaf Waggass
Journal:  Cureus       Date:  2022-02-20

8.  Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort.

Authors:  Katarina Dathe; Johanna Frank; Stephanie Padberg; Stefanie Hultzsch; Evelin Beck; Christof Schaefer
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-26       Impact factor: 3.105

9.  Surf early to higher tides: surfactant therapy to optimize tidal volume, lung recruitment, and iNO response.

Authors:  Girija G Konduri; Satyan Lakshminrusimha
Journal:  J Perinatol       Date:  2020-08-13       Impact factor: 2.521

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.